In this 1-hour presentation, Dr. Abi.Vijenthira, hematologist at Princess Margaret Cancer Centre in Toronto, provided an overview of the approach to non-Hodgkin lymphomas, and provided updates on recent developments in the management of these lymphomas.
More specifically, Dr. Vijenthira reviewed:
- Overview of non-Hodgkin lymphomas (NHL)
- Progress in understanding and treating NHL
- Concept 1: The heterogeneity of lymphoma
- Concept 2: “Minimal residual disease” (MRD)
- Concept 3: Immunotherapy
- Updates on COVID-19
Dr. Abi Vijenthira is an Associate Professor of Medicine at the University of Toronto and staff hematologist in the Division of Medical Oncology and Hematology at Princess Margaret Cancer Centre. Dr. Vijenthira received her medical degree from the University of Ottawa and completed her Internal Medicine and Hematology residencies at the University of Toronto. She completed fellowships in Lymphoma at Princess Margaret and in CLL at Dana Farber Cancer Institute, and a Master of Science in Clinical Epidemiology at Harvard University. Dr. Vijenthira’s clinical practice involves the treatment of patients with lymphomas and her research interests include population-based outcomes and health services research in patients with lymphoma
7 сен 2024
